focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.22
Bid: 6.62
Ask: 6.98
Change: 1.46 (25.35%)
Spread: 0.36 (5.438%)
Open: 5.72
High: 7.22
Low: 5.72
Prev. Close: 5.76
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Feb 2007 15:16

Synairgen plc23 February 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of Synairgen plcexisting shares to which voting rights are attached: 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights ( ) An acquisition or disposal of financial instruments which may result in the ( )acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights ( ) Other (please specify): Confirmation of our Xholding___________________________________ 3. Full name of person(s) subject to the AMVESCAP plcnotification obligation: 4. Full name of shareholder(s) (if differentfrom 3.): 5. Date of the transaction (and date on whichthe threshold is crossed or reached ifdifferent): 6. Date on which issuer notified: 23 February 2007 7. Threshold(s) that is/are crossed or reached: 5%, 6% 8. Notified details: - A: Voting rights attached to sharesClass/type of Situation previous to the Resulting situation after the triggering transactionshares Triggering transaction if possible Number of Number of Number of Number of voting % of voting rightsusing the ISIN Shares Voting Rights shares rightsCODE Direct Direct Indirect Direct Indirect Ordinary 1p 1,314,211 1,314,211 1,314,211 1,314,211 6.05%Shares(GB00B0381Z20) B: Financial InstrumentsResulting situation after the triggering transactionType of financial Expiration date Exercise/ Conversion Number of voting rights % of votinginstrument Period/ Date that may be acquired if rights the instrument is exercised/ converted. - Total (A+B)Number of voting rights % of voting rights1,314,211 6.05% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectivelyheld, if applicable: Chase Nominees - 743,836 Vidacos Nominees - 570,375 Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold votingrights: 13. Additional information: 14. Contact name: John Ward 15. Contact telephone number: 02380 512800 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Nov 200812:15 pmRNSResult of AGM
7th Nov 20083:25 pmRNSChange of NOMAD
31st Oct 20089:00 amRNSTotal Voting Rights
20th Oct 20087:00 amRNSDirector/PDMR Shareholding and Additional Listing
10th Oct 20081:53 pmRNSPosting of 2008 Annual Report
8th Oct 20089:12 amRNSChange of Adviser Name
22nd Sep 20087:00 amRNSResearch Update
4th Aug 200810:00 amRNSDirector/PDMR Shareholding
31st Jul 20087:00 amRNSFinal Results
29th Jul 20087:00 amRNSCommencement of Clinical Tria
14th Jul 200811:48 amRNSNotice of Results
23rd May 20087:00 amRNSPresentation of data at ATS
13th Mar 20087:01 amRNSDirector Shareholding
12th Mar 20087:01 amRNSInterim Results
25th Feb 20087:01 amRNSNotice of Results
11th Feb 20087:01 amRNSPatent Granted
15th Nov 20077:01 amRNSResult of AGM
12th Nov 20078:25 amRNSContract with Alpha Biologics
31st Oct 200712:45 pmRNSDirector/PDMR Shareholding
28th Sep 20077:04 amRNSLicence/ Supply by Rentschler
26th Sep 20077:01 amRNSFinal Results
20th Aug 20077:00 amRNSNotice of Preliminary Results
17th Aug 20071:52 pmRNSAIM Rule 26
16th Aug 20072:54 pmRNSChange of Adviser
28th Jun 20072:30 pmRNSDirector/PDMR Shareholding
12th Jun 20077:02 amRNSResearch Update
20th Mar 20074:12 pmRNSHolding(s) in Company
19th Mar 20077:01 amRNSInterim Results
23rd Feb 20073:16 pmRNSHolding(s) in Company
13th Feb 20074:40 pmRNSNotice of Results
12th Dec 200611:55 amRNSTotal Voting Rights
30th Nov 20063:18 pmRNSDirector/PDMR Shareholding
15th Nov 20067:02 amRNSLicenses novel Peptide
8th Nov 200611:11 amRNSHolding(s) in Company
8th Nov 200610:21 amRNSDirector/PDMR Shareholding
18th Sep 20067:01 amRNSFinal Results
1st Sep 20067:00 amRNSNotice of Results
14th Aug 20067:04 amRNSLicensing Deal
14th Aug 20067:01 amRNSLicensing Agreement
24th May 20067:01 amRNSResearch Update
11th Apr 200612:56 pmRNSDirectorate Change
23rd Feb 20067:01 amRNSInterim Results
16th Jan 200611:00 amRNSNotice of Results
16th Nov 20053:40 pmRNSDirector/PDMR Shareholding
15th Nov 200512:15 pmRNSResult of AGM
15th Nov 20057:02 amRNSInterferon-Beta Enters Clinic
14th Nov 20057:00 amRNSChange of Adviser
27th Sep 20057:01 amRNSFinal Results
6th Sep 20059:00 amRNSNotice of Results
13th Jul 200511:18 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.